DigitalMoneyBox Signal Desk
DigitalMoneyBox Crypto market intelligence
Cryptocurrency Decrypt

Ozempic Weight-Loss Drug Linked to Blindness in New Study

Drugmaker Novo Nordisk says its product is safe, while company stock took a hit.

Ozempic Weight-Loss Drug Linked to Blindness in New Study
Drugmaker Novo Nordisk says its product is safe, while company stock took a hit.

Original source

Read on Decrypt

Related market context